GlassScriptPhysician profile
Glenn Weiss
NPI 1265410963
$1,428.70
in general payments reported to CMS, 2019-2025
20 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $135 · 2021: $182 · 2022: $82.10 · 2023: $56.48 · 2024: $34.41 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $244.89 | 2021-2025 | Jublia |
| Amgen INC. | $241.27 | 2025 | Krystexxa |
| Abbott Laboratories | $180.10 | 2025 | Esprit |
| Smith+Nephew, INC. | $125.00 | 2019 | |
| Melinta Therapeutics, LLC | $122.90 | 2019 | |
| Crossroads Extremity Systems, LLC | $111.84 | 2020 | |
| Sandoz INC. | $104.04 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $41.48 | 2021 | |
| Paratek Pharmaceuticals, INC. | $39.22 | 2021 | |
| Sun Pharmaceutical Industries INC. | $34.41 | 2024 | |
| Integra Lifesciences Corporation | $32.33 | 2019 | |
| Bioventus LLC | $27.25 | 2019 | |
| Sebela Pharmaceuticals INC. | $22.45 | 2022 | |
| Fidia Pharma USA INC. | $19.86 | 2019 | |
| Orthofix Medical, INC. | $16.96 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $14.40 | 2019 | |
| Merck Sharp & Dohme LLC | $13.90 | 2019 | |
| Arthrosurface Incorporated | $12.90 | 2019 | |
| Grt US Holding, INC. | $11.76 | 2021 | |
| Horizon Therapeutics Plc | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.